Rzagalinski Ignacy, Rao Viditha, Bogdanova Aliona, Hersemann Lena, Shevchenko Andrej
Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany.
Methods Mol Biol. 2025;2914:65-74. doi: 10.1007/978-1-0716-4462-1_6.
Absolute (molar) quantification of proteins in cerebrospinal fluid (CSF) provides reference values and ranges of their physiological variation for perspective biomarkers across a broad spectrum of neurological disorders. FastCAT (for Fast-track QconCAT) method employs targeted mass spectrometry and multiple recombinant stable-isotope labeled chimeric proteins (CPs) as internal calibrants for the accurate and consistent determination of molar concentrations of dozens of CSF proteins. No purification or external quantification of CPs is required. We demonstrate that FastCAT, powered by parallel reaction monitoring (PRM) detection of multiple quantotypic peptides per target proteins, can quantify the molar concentration of neurological biomarkers from neat CSF over a dynamic range of more than 1000-fold, with high precision (coefficient of variation <20%) and low detection limits (<1 nmol/L) in a single LC-MS/MS analysis.
脑脊液(CSF)中蛋白质的绝对(摩尔)定量可为广泛的神经系统疾病中的潜在生物标志物提供参考值及其生理变化范围。FastCAT(快速定量串联质量标签)方法采用靶向质谱法和多种重组稳定同位素标记的嵌合蛋白(CPs)作为内部校准物,用于准确一致地测定数十种脑脊液蛋白的摩尔浓度。无需对CPs进行纯化或外部定量。我们证明,FastCAT通过对每个目标蛋白的多个定量肽进行平行反应监测(PRM)检测,能够在单次液相色谱-串联质谱(LC-MS/MS)分析中,在超过1000倍的动态范围内,高精度(变异系数<20%)且低检测限(<1 nmol/L)地定量测定未经处理的脑脊液中神经生物标志物的摩尔浓度。